This site is intended for healthcare professionals

Sign in
Go to /sign-in page

You can view 5 more pages before signing in

Prognosis

Last reviewed dd mmm yyyy. Last edited dd mmm yyyy

Authoring team

In the absence of treatment, PBC is a slowly progressive disease, with the majority of patients advancing 1 histologic stage every 2 years and the median survival of symptomatic and asymptomatic patients being 7.5 and 16 years, respectively

  • most asymptomatic patients will develop symptoms over the course of 4.5 to 17.8 years, and survival among PBC patients without symptoms is still worse than that of a similar control population

  • in addition to the risk of cirrhosis and its inherent complications, approximately 50% of PBC patients experience the symptoms of fatigue and pruritus

  • patients with cirrhosis from advanced PBC are subject to all the usual complications of cirrhosis, including hepatoma (hepatocellular carcinoma) development, spontaneous bacterial peritonitis, hepatic encephalopathy, hepatorenal syndrome, and oesophageal variceal bleeding

Reference:

Related pages

Create an account to add page annotations

Create a free account

Add information to this page that would be handy to have on hand during a consultation, such as a web address or phone number. This information will always be displayed when you visit this page

The content herein is provided for informational purposes and does not replace the need to apply professional clinical judgement when diagnosing or treating any medical condition. A licensed medical practitioner should be consulted for diagnosis and treatment of any and all medical conditions.

Connect

Copyright 2024 Oxbridge Solutions Limited, a subsidiary of OmniaMed Communications Limited. All rights reserved. Any distribution or duplication of the information contained herein is strictly prohibited. Oxbridge Solutions receives funding from advertising but maintains editorial independence.